Results 251 to 260 of about 579,790 (305)

Interleukin-17/β-Defensin-2 Expression Before and After Periodontal Therapy in a Patient With Periodontitis/Autoimmunity. [PDF]

open access: yesCureus
Ramírez-Thomé SK   +8 more
europepmc   +1 more source

Interleukin-17

International Reviews of Immunology, 1998
The particular interest of IL-17, a homodimeric cytokine of about 32 kDa, is the strict requirement for an activation signal to induce its expression from a rather restricted set of cells, human memory T cells or mouse alpha beta TCR+CD4-CD8- thymocytes.
F, Fossiez   +5 more
openaire   +2 more sources

Measurement of Interleukin‐17

Current Protocols in Immunology, 2007
AbstractUpon antigenic stimulation, naive CD4+ T cells undergo proliferation and differentiate into cytokine‐producing T helper (TH) effector cells. TH1 cells secrete effector cytokine IFN‐γ and regulate cell‐mediated immunity, whereas TH2 cells produce IL‐4, IL‐5, and IL‐13 cytokines, and mediate immunity against extracellular pathogens and allergic ...
Bhanu P, Pappu, Chen, Dong
openaire   +2 more sources

Interleukin-8 and Interleukin-17 for Cancer

Cancer Investigation, 2014
Pro-inflammatory cytokines have been associated with chronic inflammation and inflammatory diseases. Increased levels of interleukins (ILs) have been associated with inflammatory disease exacerbation. ILs levels have been observed to be associated with advance stage cancer for several types of cancer and a poor prognostic maker for malignant disease ...
Paul, Zarogoulidis   +5 more
openaire   +2 more sources

The role of interleukin-17 in epilepsy

Epilepsy Research, 2022
Epilepsy is a common neurological disorder that seriously affects human health. It is a chronic central nervous system dysfunction caused by abnormal discharges of neurons. About 50 million patients worldwide are affected by epilepsy. Although epileptic symptoms of most patients are controllable, some patients with refractory epilepsy have no response ...
Jiayin, An   +6 more
openaire   +2 more sources

Interleukin-17 in Inflammatory Myopathies

Current Rheumatology Reports, 2012
Since the identification of interleukin (IL)-17 as a T-cell-derived cytokine 15 years ago, the contribution of the T-helper type 17 (Th17) pathway in inducing and maintaining chronic inflammation has been well-established, particularly in rheumatoid arthritis. In addition to the main Th1 profile first suggested to contribute to inflammatory myopathies,
Anne, Tournadre, Pierre, Miossec
openaire   +2 more sources

Interleukin-17 and the interleukin-17 family member network.

Allergy and asthma proceedings, 2004
Interleukin-17 (now known as IL-17A), is a homodimer of two 155 amino acid chains secreted by CD4+ activated memory T cells (CD45+ RO+) and is available as a glycosylated 20- to 30-kDa homodimeric peptide. Human IL-17 shows amino acid sequence identity of 62.5 and 58% to the mouse and rat sequences, respectively.
HUANG SH   +14 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy